Literature DB >> 28743729

Obesity is associated with an altered HDL subspecies profile among adolescents with metabolic disease.

W Sean Davidson1, Anna Heink2, Hannah Sexmith2, Lawrence M Dolan2, Scott M Gordon3, James D Otvos4, John T Melchior1, Deborah A Elder2, Jane Khoury2, Esmond Geh2, Amy S Shah5.   

Abstract

We aimed to determine the risk factors associated with the depletion of large HDL particles and enrichment of small HDL particles observed in adolescents with T2D. Four groups of adolescents were recruited: 1) lean insulin-sensitive (L-IS), normal BMI and no insulin resistance; 2) lean insulin-resistant (L-IR), normal BMI but insulin resistance (fasting insulin levels ≥ 25 mU/ml and homeostatic model assessment of insulin resistance ≥ 6); 3) obese insulin-sensitive (O-IS), BMI ≥ 95th percentile and no insulin resistance; and 4) obese insulin-resistant (O-IR), BMI ≥ 95th percentile and insulin resistance. Plasma was separated by using gel-filtration chromatography to assess the HDL subspecies profile and compared with that of obese adolescents with T2D (O-T2D). Large HDL subspecies were significantly lower across groups from L-IS > L-IR > O-IS > O-IR > O-T2D (P < 0.0001); small HDL particles were higher from L-IS to O-T2D (P < 0.0001); and medium-sized particles did not differ across groups. The contributions of obesity, insulin resistance, and diabetes to HDL subspecies profile were between 23% and 28%, 1% and 10%, and 4% and 9%, respectively. Obesity is the major risk factor associated with the altered HDL subspecies profile previously reported in adolescents with T2D, with smaller contributions from insulin resistance and diabetes.
Copyright © 2017 by the American Society for Biochemistry and Molecular Biology, Inc.

Entities:  

Keywords:  diabetes; high density lipoprotein; insulin resistance; phospholipids

Mesh:

Substances:

Year:  2017        PMID: 28743729      PMCID: PMC5580903          DOI: 10.1194/jlr.M078667

Source DB:  PubMed          Journal:  J Lipid Res        ISSN: 0022-2275            Impact factor:   5.922


  45 in total

Review 1.  Lipoprotein particle analysis by nuclear magnetic resonance spectroscopy.

Authors:  Elias J Jeyarajah; William C Cromwell; James D Otvos
Journal:  Clin Lab Med       Date:  2006-12       Impact factor: 1.935

2.  Standards of medical care in diabetes--2014.

Authors: 
Journal:  Diabetes Care       Date:  2014-01       Impact factor: 19.112

3.  High-density lipoprotein cholesterol and particle concentrations, carotid atherosclerosis, and coronary events: MESA (multi-ethnic study of atherosclerosis).

Authors:  Rachel H Mackey; Philip Greenland; David C Goff; Donald Lloyd-Jones; Christopher T Sibley; Samia Mora
Journal:  J Am Coll Cardiol       Date:  2012-07-11       Impact factor: 24.094

4.  Oxidatively modified low density lipoproteins: a potential role in recruitment and retention of monocyte/macrophages during atherogenesis.

Authors:  M T Quinn; S Parthasarathy; L G Fong; D Steinberg
Journal:  Proc Natl Acad Sci U S A       Date:  1987-05       Impact factor: 11.205

5.  Early incorporation of cell-derived cholesterol into pre-beta-migrating high-density lipoprotein.

Authors:  G R Castro; C J Fielding
Journal:  Biochemistry       Date:  1988-01-12       Impact factor: 3.162

6.  Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy.

Authors:  William E Boden; Jeffrey L Probstfield; Todd Anderson; Bernard R Chaitman; Patrice Desvignes-Nickens; Kent Koprowicz; Ruth McBride; Koon Teo; William Weintraub
Journal:  N Engl J Med       Date:  2011-11-15       Impact factor: 91.245

7.  Proteomic characterization of human plasma high density lipoprotein fractionated by gel filtration chromatography.

Authors:  Scott M Gordon; Jingyuan Deng; L Jason Lu; W Sean Davidson
Journal:  J Proteome Res       Date:  2010-10-01       Impact factor: 4.466

8.  Gender and racial differences in lipoprotein subclass distributions: the STRRIDE study.

Authors:  Johanna L Johnson; Cris A Slentz; Brian D Duscha; Gregory P Samsa; Jennifer S McCartney; Joseph A Houmard; William E Kraus
Journal:  Atherosclerosis       Date:  2004-10       Impact factor: 5.162

9.  LDL Particle Number and Risk of Future Cardiovascular Disease in the Framingham Offspring Study - Implications for LDL Management.

Authors:  William C Cromwell; James D Otvos; Michelle J Keyes; Michael J Pencina; Lisa Sullivan; Ramachandran S Vasan; Peter W F Wilson; Ralph B D'Agostino
Journal:  J Clin Lipidol       Date:  2007-12       Impact factor: 4.766

10.  Novel Pathways of Apolipoprotein A-I Metabolism in High-Density Lipoprotein of Different Sizes in Humans.

Authors:  Carlos O Mendivil; Jeremy Furtado; Allyson M Morton; Liyun Wang; Frank M Sacks
Journal:  Arterioscler Thromb Vasc Biol       Date:  2015-11-05       Impact factor: 8.311

View more
  6 in total

1.  Postprandial remodeling of high-density lipoprotein following high saturated fat and high carbohydrate meals.

Authors:  Michelle Averill; Katya B Rubinow; Kevin Cain; Jake Wimberger; Ilona Babenko; Jessica O Becker; Karen E Foster-Schubert; David E Cummings; Andrew N Hoofnagle; Tomas Vaisar
Journal:  J Clin Lipidol       Date:  2019-11-22       Impact factor: 4.766

2.  High density lipoprotein proteome is associated with cardiovascular risk factors and atherosclerosis burden as evaluated by coronary CT angiography.

Authors:  Scott M Gordon; Jonathan H Chung; Martin P Playford; Amit K Dey; Denis Sviridov; Fayaz Seifuddin; Yun-Ching Chen; Mehdi Pirooznia; Marcus Y Chen; Nehal N Mehta; Alan T Remaley
Journal:  Atherosclerosis       Date:  2018-09-25       Impact factor: 5.162

Review 3.  The Difference Between High Density Lipoprotein Subfractions and Subspecies: an Evolving Model in Cardiovascular Disease and Diabetes.

Authors:  W Sean Davidson; Allison L Cooke; Debi K Swertfeger; Amy S Shah
Journal:  Curr Atheroscler Rep       Date:  2021-03-27       Impact factor: 5.113

Review 4.  Obesity-Related Changes in High-Density Lipoprotein Metabolism and Function.

Authors:  Julia T Stadler; Gunther Marsche
Journal:  Int J Mol Sci       Date:  2020-11-26       Impact factor: 5.923

5.  HDL Particle Subspecies and Their Association With Incident Type 2 Diabetes: The PREVEND Study.

Authors:  Sara Sokooti; Jose L Flores-Guerrero; Lyanne M Kieneker; Hiddo J L Heerspink; Margery A Connelly; Stephan J L Bakker; Robin P F Dullaart
Journal:  J Clin Endocrinol Metab       Date:  2021-05-13       Impact factor: 5.958

6.  High-Density Lipoprotein Particles and Their Relationship to Posttransplantation Diabetes Mellitus in Renal Transplant Recipients.

Authors:  Sara Sokooti; Tamas Szili-Torok; Jose L Flores-Guerrero; Maryse C J Osté; António W Gomes-Neto; Jenny E Kootstra-Ros; Hiddo J L Heerspink; Margery A Connelly; Stephan J L Bakker; Robin P F Dullaart
Journal:  Biomolecules       Date:  2020-03-21
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.